Switch to:
Valeant Pharmaceuticals International Inc (NYSE:VRX)
EV/EBITDA
9.75 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Valeant Pharmaceuticals International Inc's enterprise value is $38,816 Mil. Valeant Pharmaceuticals International Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2016 was $3,983 Mil. Therefore, Valeant Pharmaceuticals International Inc's EV/EBITDA ratio for today is 9.75.

VRX' s EV/EBITDA Range Over the Past 10 Years
Min: -31   Max: 106.7
Current: 9.49

-31
106.7

During the past 13 years, the highest EV/EBITDA Ratio of Valeant Pharmaceuticals International Inc was 106.70. The lowest was -31.00. And the median was 13.90.

VRX's EV/EBITDA is ranked higher than
74% of the 568 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 16.55 vs. VRX: 9.49 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Valeant Pharmaceuticals International Inc's stock price is $20.27. Valeant Pharmaceuticals International Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2016 was $-2.13. Therefore, Valeant Pharmaceuticals International Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Valeant Pharmaceuticals International Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=38816.137/3982.9
=9.75

Valeant Pharmaceuticals International Inc's current Enterprise Value is $38,816 Mil.
Valeant Pharmaceuticals International Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2016 was 983 (Jun. 2015 ) + 1140.9 (Sep. 2015 ) + 1051.3 (Dec. 2015 ) + 807.7 (Mar. 2016 ) = $3,983 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Valeant Pharmaceuticals International Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=20.27/-2.129
=

Valeant Pharmaceuticals International Inc's share price for today is $20.27.
Valeant Pharmaceuticals International Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2016 was -0.15 (Jun. 2015 ) + 0.14 (Sep. 2015 ) + -1.039 (Dec. 2015 ) + -1.08 (Mar. 2016 ) = $-2.13.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Valeant Pharmaceuticals International Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -22.534.896.066.64113.5522.9626.1336.9417.3717.05

Valeant Pharmaceuticals International Inc Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2ebitda 36.9435.7228.1819.5917.3725.3026.5422.7917.0510.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK